Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “The Neoadjuvant Therapy”

1,691 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,691 results

Testing effectiveness (Phase 2)UnknownNCT05885386
What this trial is testing

A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL

Who this might be right for
PheochromocytomaParaganglioma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06066437
What this trial is testing

NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 6
Not applicableWithdrawnNCT04670588
What this trial is testing

Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2
Testing effectiveness (Phase 2)UnknownNCT04180995
What this trial is testing

Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
Peking University Cancer Hospital & Institute 30
Not applicableUnknownNCT05964595
What this trial is testing

Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant Therapy

Who this might be right for
Head and Neck Squamous Cell CarcinomaMagnetic Resonance ImagingNeoadjuvant Therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 136
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Not applicableActive Not RecruitingNCT05985551
What this trial is testing

Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment

Who this might be right for
Breast CancerChemotherapy EffectSentinel Lymph Node
Uppsala University 114
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Not applicableStudy completedNCT06630481
What this trial is testing

Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
Seoul National University Hospital 462
Testing effectiveness (Phase 2)UnknownNCT02506777
What this trial is testing

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
N.N. Petrov National Medical Research Center of Oncology 96
Large-scale testing (Phase 3)Study completedNCT02157311
What this trial is testing

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 100
Testing effectiveness (Phase 2)Study completedNCT00343239
What this trial is testing

Docetaxel in Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Sanofi 59
Testing effectiveness (Phase 2)Study completedNCT00408564
What this trial is testing

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Medical University of South Carolina 39
Not applicableUnknownNCT03577132
What this trial is testing

The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer

Who this might be right for
Urothelial Carcinoma
Seoul National University Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04617457
What this trial is testing

Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerMetastasisSurgery+1 more
University of Cologne 150
Testing effectiveness (Phase 2)Study completedNCT02927301
What this trial is testing

Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 181
Testing effectiveness (Phase 2)Study completedNCT03088930
What this trial is testing

Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Nonsmall Cell
University of Colorado, Denver 3
Large-scale testing (Phase 3)Active Not RecruitingNCT04927780
What this trial is testing

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaResectable Pancreatic Adenocarcinoma
Erasmus Medical Center 378
Next Page